Endospan Ltdis A Medical Device Company Based In Herzliyaisraelfounded In 2009The Company Specializes In The Endovascular Repair Of Aortic Arch Diseasesfocusing On Innovative Solutions For Treating Various Aortic Pathologiesendospan S Primary Product Is The Nexus Aortic Arch Stent Graft Systemdesigned For Minimally Invasive Treatment Of Aortic Arch Aneurysms And Related Conditionsthey Also Offer The Nexus Duoa Custom Made Stent Graft System That Enhances Personalized Treatment Options For Complex Aortic Arch Diseasesthe Company Is Actively Involved In Clinical Researchparticularly The Triomphe Ide Studywhich Evaluates The Safety And Efficacy Of Their Stent Graft Systemled By Ceo Kevin Mayberryendospan Has A Dedicated Team Of Around 50 Employeesthe Company Has Filed Numerous Patents Related To Its Medical Devicesshowcasing Its Commitment To Innovation In The Field Of Vascular Surgery
